Tuesday, April 19, 2016

J&J Beats


Hmmmm... Another 1Q beat who could ever have seen this coming... I thought we were going second leg down?  Gee I wonder where J&J gets the munnie for their pharma?


Johnson & Johnson reported earnings that beat analysts’ estimates on strong sales of pharmaceuticals, the company’s biggest division. Drugs including Stelara, a psoriasis drug, and Xarelto, a blood thinner, were among the company’s major drug products that surpassed analysts’ expectations. 
Pharmaceutical sales have surpassed medical devices and consumer health products to become New Brunswick, New Jersey-based J&J’s biggest division.



2 comments:

Michael Norman said...

Yeah, and there's a recession coming. The shrinking deficit is telling me that. It's been telling me that for three years. You'll see. It's coming.

Tom Hickey said...

Again it's left up to the US economy to pull the global economy out of the doldrums, or worse.

But in the past that job has fallen to indefatigable US consumers taking on more and more debt. It's questionable the degree to which that will happen this time around.